Sofosbuvir/velpatasvir/voxilaprevir: a review in chronic hepatitis C
YA Heo, ED Deeks - Drugs, 2018 - Springer
A fixed-dose combination of the hepatitis C virus (HCV) NS5B polymerase inhibitor
sofosbuvir, the HCV NS5A inhibitor velpatasvir and the HCV NS3/4A protease inhibitor …
sofosbuvir, the HCV NS5A inhibitor velpatasvir and the HCV NS3/4A protease inhibitor …
[HTML][HTML] Hepatitis C virus: Promising discoveries and new treatments
JCS Bastos, MA Padilla, LC Caserta… - World journal of …, 2016 - ncbi.nlm.nih.gov
Despite advances in therapy, hepatitis C virus (HCV) infection remains an important global
health issue. It is estimated that a significant part of the world population is chronically …
health issue. It is estimated that a significant part of the world population is chronically …
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan
Background The approval of lecanemab, an anti-amyloid therapy for Alzheimer's disease
(AD), necessitates addressing healthcare preparedness for disease-modifying treatment …
(AD), necessitates addressing healthcare preparedness for disease-modifying treatment …
Economic consequences of investing in anti-HCV antiviral treatment from the Italian NHS perspective: a real-world-based analysis of PITER data
Objective We estimated the cost consequence of Italian National Health System (NHS)
investment in direct-acting antiviral (DAA) therapy according to hepatitis C virus (HCV) …
investment in direct-acting antiviral (DAA) therapy according to hepatitis C virus (HCV) …
Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy
Abstract Background Hepatitis C virus (HCV) infection represents a global health issue with
severe implications on morbidity and mortality. This study aimed to evaluate the impact of …
severe implications on morbidity and mortality. This study aimed to evaluate the impact of …
Treatment as prevention: should hepatitis C learn the lessons from HIV?
JV Fernandez-Montero, EJ Aspinall, JE Burns - AIDS reviews, 2017 - discovery.ucl.ac.uk
Long-term experience in the treatment of HIV-infected individuals has shown indirect
benefits of early initiation of antiretroviral therapy, particularly in preventing HIV …
benefits of early initiation of antiretroviral therapy, particularly in preventing HIV …
Противовирусное лечение хроническогогепатита с: имеющиеся результаты и будущие перспективы
ВМ Мицура, ЕЛ Красавцев… - … здоровья и экологии, 2017 - cyberleninka.ru
Цель: оценить результативность двухкомпонентной противовирусной терапии ХВГС
(ИФН/РБВ или ПЭГ-ИФН/РБВ) с учетом генотипа HCV, наличия мутаций гена ИЛ-28B и …
(ИФН/РБВ или ПЭГ-ИФН/РБВ) с учетом генотипа HCV, наличия мутаций гена ИЛ-28B и …
Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients
Background Direct-acting antivirals (DAA) have dramatically increased HCV cure rates with
minimal toxicity in HIV-HCV co-infected patients. This study aimed to compare the socio …
minimal toxicity in HIV-HCV co-infected patients. This study aimed to compare the socio …
[PDF][PDF] Ethische Sichtweise auf hochpreisige Arzneimittel
E Nagel, D Henzler, M Lauerer - Arzneimittel-Kompass 2021 …, 2021 - library.oapen.org
Die Zulassung und Preisbildung neuer Arzneimittel ist in Deutschland, wie in vielen anderen
Ländern, reglementiert. Damit fügen sie sich in die umfänglichen Vorgaben zur …
Ländern, reglementiert. Damit fügen sie sich in die umfänglichen Vorgaben zur …
Hepatitis C Treatment in HIV Coinfection: Approaches, Challenges, and Future Opportunities
A Bagwell, CA Chastain - Current Treatment Options in Infectious …, 2016 - Springer
Opinion statement Human immunodeficiency virus (HIV) and hepatitis C virus (HCV)
coinfection is a significant cause of morbidity and mortality in people living with HIV/AIDS …
coinfection is a significant cause of morbidity and mortality in people living with HIV/AIDS …